Suchergebnisse - (Person:"Ma, Fei")

PubPharm (13)

1

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

2

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Cancer communications | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

3

Polymorphisms of MTHFR and TYMS predict capecitabine-induced hand-foot syndrome in patients with metastatic breast cancer

enthalten in: Chinese journal of cancer | 2019

von Lin, S. | Yue, J. | Guan, X. | +11

4

Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab : A Randomized, Phase II Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Ma, F. | Ouyang, Q. | Li, W. | +11

5

Safety, Efficacy, and Biomarker Analysis of Pyrotinib in Combination with Capecitabine in HER2-Positive Metastatic Breast Cancer Patients : A Phase I Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2019

von Li, Q. | Guan, X. | Chen, S. | +16

6

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer

enthalten in: Cancer communications (London, England) | 2019

von Guan, X. | Ma, F. | Li, C. | +13

7

Efficacy and safety of cisplatin plus capecitabine for patients with metastatic triple negative breast cancer progressing after anthracycline and taxane treatment

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2015

von Li, Q. | Xu, B. | Li, Q. | +7

8

Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2015

von Du, F. | Yuan, P. | Luo, Y. | +7

9

Capecitabine combined with docetaxel versus vinorelbine followed by capecitabine maintenance medication for first-line treatment of patients with advanced breast cancer : Phase 3 randomized trial

enthalten in: Cancer | 2015

von Wang, J. | Xu, B. | Yuan, P. | +7

10

A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes

enthalten in: Cancer biology & therapy | 2015

von Li, Q. | Li, Q. | Zhang, P. | +7